Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Targeted Protein Degradation | Q&As & Interviews

Interview with Yusuke Tominari, Co founder and CEO of Fimecs

Edited by Tom Cohen | 03 July 2023
Yusuke will be giving a keynote presentation at Discovery Europe 2023 titled 'Targeted Protein Degradation And Addressing Undruggable Targets'.
https://www.youtube.com/watch?v=ErvYS8fiCis&ab_channel=OxfordGlobalMarketingLtd

Visit our Discovery Portal to learn more about the latest research into drug design, development, and more. If you’d like to register your interest for Oxford Global‘s upcoming conference, Organ Modelling 2023, click here.

Get your weekly dose of industry news?here?and keep up to date with the latest?‘Industry Spotlight’ posts.?For other Discovery content, please visit the?Discovery Content Portal.

Related Resources

From Screening to Success: How Molecular 'Super-Glue' SJ3149, Could Advance Cancer Treatments

Researchers at St Jude Children's Research Hospital used high throughput screening (HTS) to identify SJ3149, a molecular glue degrader. This small molecule demonstrated efficacy across a range of cancer types.
Read More

Targeting Novel E3 Ubiquitin Ligases: Carles Galdeano, Professor, University of Barcelona

We discuss working on PROTACs, targeting novel E3 ubiquitin ligases, and Dr Galdeano's spin out Oniria Therapeutics.
Read More